MA43507B1 - Mono or di-substituted indole derivatives as dengue virus replication inhibitors - Google Patents
Mono or di-substituted indole derivatives as dengue virus replication inhibitorsInfo
- Publication number
- MA43507B1 MA43507B1 MA43507A MA43507A MA43507B1 MA 43507 B1 MA43507 B1 MA 43507B1 MA 43507 A MA43507 A MA 43507A MA 43507 A MA43507 A MA 43507A MA 43507 B1 MA43507 B1 MA 43507B1
- Authority
- MA
- Morocco
- Prior art keywords
- dengue virus
- compounds
- mono
- virus replication
- indole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des composés indole monosubstitués ou disubstitués, des méthodes pour prévenir ou traiter les infections provoquées par le virus de la dengue à l'aide de tels composés. La présente invention concerne également lesdits composés qui sont destinés à être utilisés en tant que médicaments, de préférence destinés à être utilisés en tant que médicaments pour traiter ou prévenir les infections provoquées par le virus de la dengue. La présente invention concerne en outre des compositions pharmaceutiques ou des préparations combinées de ces composés, des compositions ou des préparations qui sont utilisées en tant que médicaments, de préférence pour la prévention ou le traitement d'infections provoquées par le virus de la dengue. L'invention concerne également des procédés de préparation de ces composés.The present invention relates to monosubstituted or disubstituted indole compounds, methods for preventing or treating infections caused by dengue virus using such compounds. The present invention also relates to said compounds which are intended for use as medicaments, preferably for use as medicaments for treating or preventing infections caused by the dengue virus. The present invention further relates to pharmaceutical compositions or combined preparations of these compounds, compositions or preparations which are used as medicaments, preferably for the prevention or treatment of infections caused by the dengue virus. The invention also relates to methods of preparing these compounds.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15166900 | 2015-05-08 | ||
| PCT/EP2016/059975 WO2016180696A1 (en) | 2015-05-08 | 2016-05-04 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43507B1 true MA43507B1 (en) | 2021-08-31 |
Family
ID=53059008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA43507A MA43507B1 (en) | 2015-05-08 | 2016-05-04 | Mono or di-substituted indole derivatives as dengue virus replication inhibitors |
Country Status (3)
| Country | Link |
|---|---|
| AR (2) | AR104504A1 (en) |
| MA (1) | MA43507B1 (en) |
| MY (1) | MY185672A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114989131B (en) * | 2022-05-30 | 2023-10-24 | 云南大学 | N' - (2- (benzo [1,3] dioxolan-5-yl) acyl) aryl hydrazide compound as well as synthesis and application thereof |
-
2016
- 2016-05-03 AR ARP160101248A patent/AR104504A1/en unknown
- 2016-05-04 MY MYPI2017001601A patent/MY185672A/en unknown
- 2016-05-04 MA MA43507A patent/MA43507B1/en unknown
-
2020
- 2020-10-05 AR ARP200102756A patent/AR120158A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR120158A2 (en) | 2022-02-02 |
| AR104504A1 (en) | 2017-07-26 |
| MY185672A (en) | 2021-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA40768A (en) | MONO OR DI-SUBSTITUTE INDOLE DERIVATIVES AS DENGUE VIRUS REPLICATION INHIBITORS | |
| MA42811B1 (en) | Monosubstituted or disubstituted indole derivatives used as inhibitors of dengue virus replication | |
| MA40769B1 (en) | Mono- or di-substituted isolates used as replication inhibitors of dengue virus | |
| MA40111A1 (en) | Derivatives of tetrahydronaphthalene inhibiting mcl-1 protein | |
| MA53399B1 (en) | Substituted pyrazoles as inhibitors of human plasma kallikrein | |
| PH12018502026A1 (en) | Substituted indole compound derivatives as dengue viral replication inhibitors | |
| MA45153B1 (en) | Substituted carbonucleoside derivatives useful as anticancer agents | |
| PH12019502577A1 (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| PH12019502201A1 (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| PH12018502077A1 (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| PH12018502015A1 (en) | Substituted indole derivatives as dengue viral replication inhibitors | |
| MA42230B1 (en) | Bicyclic derivatives, process for their preparation, and pharmaceutical compositions containing them | |
| PH12019502095A1 (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| PH12018502016A1 (en) | Substituted indole derivatives as dengue viral replication inhibitors | |
| PH12019502559A1 (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| MX2022000453A (en) | Compounds useful to treat influenza virus infections. | |
| MA45782B1 (en) | Modulators of the cxcr7 piperidine receptor | |
| MA43913B1 (en) | Positive allosteric modulators of the m1 muscarinic receptor | |
| MA43052B1 (en) | Human Plasma Kallikrein Inhibitors | |
| MA42769B1 (en) | Fluoroindole derivatives as positive allosteric modulators of the m1 muscarinic receptor | |
| MA41174B1 (en) | Imidazopyridazine derivatives used as pi3kbeta inhibitors | |
| MA39253A1 (en) | Substituted bicyclic heteroaryl compounds used as rxr agonists | |
| MA43507B1 (en) | Mono or di-substituted indole derivatives as dengue virus replication inhibitors | |
| MA49994A1 (en) | Macrocyclic compounds for the treatment of disease | |
| FR3042191B1 (en) | 1,4,8-TRIAZAPHENANTHRENE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |